Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera
Covid19-Sources
Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events
Effectiveness of the BNT162b2 mRNA COVID-19...
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
Analysis of the Dynamics, Outcome, and Prerequisites of the first German SARS-CoV-2 Superspreading Event
Tom Folan on Twitter
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution
Pamela P. Martinez on Twitter
Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination
Shedding of Infectious SARS-CoV-2 Despite Vaccination
COVID-19 Long-Haulers Are Fighting for Their Future - The Atlantic
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM
Ein paar Worte zu Impfung und Immunität
Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection
Systemic COVID-19 vaccination also enhances the humoral immune response after SARS CoV-2 infection. An approach to criteria for COVID-19 re-immunization is needed. Do we need a third dose?
Hendrik Streeck liegt ständig falsch, aber die Talkshows laden ihn …
Pressemitteilung
New SARS-CoV-2 variants have changed the pandemic. What will the virus do next?
Misinformation can prevent the suppression of epidemics
Seroconversion and fever are dose-pependent in a nonhuman primate model of inhalational COVID-19
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Novavax gibt Daten zum COVID-19-Auffrischimpfung bekannt, die einen vierfachen Anstieg der neutralisierenden Antikörperspiegel im Vergleich zu den Spitzenwerten nach der Erstimpfung belegen
New COVID-19 Cases and Hospitalizations Among...
mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern